What medication is commonly used for patients with rapid AFib?

What medication is commonly used for patients with rapid AFib?

• A. Calcium channel blockers
• B. Anticoagulants
• C. Beta-blockers
• D. Diuretics

Answer: (C)

The use of beta-blockers for patients with rapid atrial fibrillation (AFib) is important due to their effectiveness in managing the heart rate and improving overall cardiovascular stability. Beta-blockers work by blocking the effects of adrenaline on the heart, which slows down the heart rate and reduces the force of contraction. This can help control the rapid heart rate commonly seen in AFib and protect the heart from the potential complications of this arrhythmia. In contrast, while calcium channel blockers are also utilized for rate control in AFib, the specific efficacy and first-line consideration in many cases often lead to the preference of beta-blockers. Anticoagulants are vital in reducing the risk of stroke in AFib patients but do not directly influence heart rate. Diuretics may be helpful for managing symptoms related to fluid retention but do not address the arrhythmia itself. Thus, the selection of beta-blockers is pivotal for rate control in acute management of rapid AFib.

The use of beta-blockers for patients with rapid atrial fibrillation (AFib) is important due to their effectiveness in managing the heart rate and improving overall cardiovascular stability. Beta-blockers work by blocking the effects of adrenaline on the heart, which slows down the heart rate and reduces the force of contraction. This can help control the rapid heart rate commonly seen in AFib and protect the heart from the potential complications of this arrhythmia.

In contrast, while calcium channel blockers are also utilized for rate control in AFib, the specific efficacy and first-line consideration in many cases often lead to the preference of beta-blockers. Anticoagulants are vital in reducing the risk of stroke in AFib patients but do not directly influence heart rate. Diuretics may be helpful for managing symptoms related to fluid retention but do not address the arrhythmia itself. Thus, the selection of beta-blockers is pivotal for rate control in acute management of rapid AFib.